Skip to main content
Premium Trial:

Request an Annual Quote

Boston Children's Hospital: Wendy Chung

Wendy Chung has been appointed as chief of the department of pediatrics at Boston Children's Hospital. She will also become a professor at Harvard Medical School and president of Children's Hospital Pediatric Associates. Chung joins Boston Children's from Columbia University Irving Medical Center/NewYork-Presbyterian Morgan Stanley Children's Hospital, where she was chief of the division of clinical genetics in the department of pediatrics, as well as associate director for education at the Herbert Irving Comprehensive Cancer Center, medical director for the Columbia genetic counseling graduate program, and precision medicine resource leader at the Irving Institute. In addition, she was a professor of pediatrics and medicine and led a laboratory at Columbia University Medical Center. Chung also currently serves as director of clinical research at the Simons Foundation Autism Research Initiative. She holds a BA in biochemistry and economics from Cornell University, an MD from Cornell University Medical College, and a PhD in genetics from Rockefeller University.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.